{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:05:31Z","timestamp":1755223531460,"version":"3.43.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study aimed to understand if resection (RS) for nonmetastatic small bowel neuroendocrine tumors (SBNETs) prolongs 5-year overall survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients from National Cancer Data Base with primary histologically confirmed SBNETs from 2007 to 2016 were included. Patients younger than 18 years, with the disease in the duodenum\/Meckel diverticulum or metastatic disease were excluded. We assessed 5-year survival rates using Kaplan-Meier curves and multivariate Cox proportional hazards regression after RS, nonresection surgical management (NRS), or no resection (NR). Multivariate models were adjusted with age, sex, race, insurance, Charlson-Deyo comorbidity score, academic facility, primary tumor location, clinical T, clinical N, stage, and grade.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 4180 patients. On average, patients were 64 years old (standard deviation, 12 years), male (53%), and White (84%). The majority received RS (91.8%) as opposed to NRS (4.0%) or NR (4.2%). Patients who received RS versus NR had increased survival rates (84.2% vs 73.9%; univariate log-rank, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001; multivariate hazard ratio, 0.73; 95% confidence interval, 0.53\u20130.99; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04). No statistical difference in survival was observed for NRS versus NR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To our knowledge, this is the first national study to evaluate survival after RS for nonmetastatic SBNETs. Results suggest that RS of SBNETs may prolong 5-year survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000001982","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T14:00:34Z","timestamp":1649685634000},"page":"171-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Resection Prolongs Overall Survival for Nonmetastatic Midgut Small Bowel Neuroendocrine Tumors"],"prefix":"10.1097","volume":"51","author":[{"given":"Venu Gopal","family":"Bangla","sequence":"first","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Wolin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Kang","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M.","family":"Divino","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250812","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","year":"2009","journal-title":"Ann Surg"},{"key":"bib2-20250812","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"bib3-20250812","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum","volume":"39","year":"2010","journal-title":"Pancreas"},{"key":"bib4-20250812","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00268-020-05689-7","article-title":"Surgical management of primary small bowel NET presenting acutely with obstruction or perforation","volume":"45","year":"2021","journal-title":"World J Surg"},{"key":"bib5-20250812","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"key":"bib6-20250812","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1177\/000313481808401006","article-title":"Long-term outcomes after elective versus emergency surgery for small bowel neuroendocrine tumors","volume":"84","year":"2018","journal-title":"Am Surg"},{"key":"bib7-20250812","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1245\/s10434-020-08695-0","article-title":"It may not be too little or too late: resecting primary small bowel neuroendocrine tumors in the presence of metastatic disease","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"bib8-20250812","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jso.24390","article-title":"Small bowel neuroendocrine tumors: a critical analysis of diagnostic work-up and operative approach","volume":"114","year":"2016","journal-title":"J Surg Oncol"},{"key":"bib9-20250812","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.surg.2018.09.006","article-title":"Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors","volume":"165","year":"2019","journal-title":"Surgery"},{"key":"bib10-20250812","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1245\/s10434-020-08602-7","article-title":"Primary tumor resection offers survival benefit in patients with metastatic midgut neuroendocrine tumors","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"bib11-20250812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.10320","article-title":"The National Cancer Data Base: a clinical surveillance and quality improvement tool","volume":"85","year":"2004","journal-title":"J Surg Oncol"},{"key":"bib12-20250812","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-017-3524-9","article-title":"Optimal lymphadenectomy in small bowel neuroendocrine tumors: analysis of the NCDB","volume":"22","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"bib13-20250812","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/bjs.7649","article-title":"Survival and prognostic factors in patients with small bowel carcinoid tumour","volume":"98","year":"2011","journal-title":"Br J Surg"},{"key":"bib14-20250812","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","year":"2012","journal-title":"World J Surg"},{"key":"bib15-20250812","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/SLA.0000000000002809","article-title":"Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment","volume":"270","year":"2019","journal-title":"Ann Surg"},{"key":"bib16-20250812","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum","volume":"103","year":"2016","journal-title":"Neuroendocrinology"},{"key":"bib17-20250812","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1245\/s10434-020-09566-4","article-title":"The landmark series: management of small bowel neuroendocrine tumors","volume":"28","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:06:06Z","timestamp":1754957166000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000001982"}},"subtitle":["A National Cancer Data Base Study"],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000001982","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"type":"electronic","value":"1536-4828"},{"type":"print","value":"0885-3177"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}